Lower riskMedical device recall · FDA · Published October 7, 2019
Sybron Legacy 3 Dental Implant Recall: Incorrect Implants May Cause Surgery Rescheduling
Sybron recalls Legacy 3 dental implants with incorrect sizes that could require surgery rescheduling. Affected units include specific dimensions and lot numbers.
“Sybron Legacy 3 Dental Implant Recall: Incorrect Implants May Cause Surgery Rescheduling.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/66873-sybron-legacy-3-dental-implant-recall-incorrect-implants-may-cause. Based on FDA recall #Z-1041-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1041-2020%22&limit=1).
The FDA announced on Oct. 7, 2019, that Sybron Manufacturing LLC voluntarily recalled Legacy 3 Implants because some packages contain incorrect implants, which could lead to surgery rescheduling.
Some dental implant packages contain incorrect implants, which could lead to surgery rescheduling.
Context
GovInfoNow's records show Implant Direct Sybron Manufacturing LLC has had 20 other recalls on record since June 26, 2017. Other recent recalls of similar products include Straumann Bone Level Tapered Implant May Be Wrong Length (July 16, 2026), Straumann Dental Implant Abutments Recall: Incorrect Screw Seat Interface Hazard (March 27, 2026), and Straumann GM Helix Dental Implant Recall: Packaging Mismatch Risk (July 13, 2026).
How to tell if you have this one
Check for the Legacy 3 implant with size 4.2mmD x 13mmL, platform 3.5mmD, and lot number 83327. The product is sold under Sybron Manufacturing LLC.
Brand
Sybron
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Implant Details
Verify the implant size, platform, and lot number to confirm if it matches the recalled model.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 15 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “U.S. Nationwide distribution in the states of: KS, LA, OH, RI, CA, NJ, MA, FL, UT, ID, MO, WY, WI, PA, WA. O.U.S. (Foreign): DE, IT, HU, JP” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Florida, Idaho, Kansas, Louisiana, Massachusetts, Missouri, New Jersey, Ohio, Pennsylvania, Rhode Island, Utah, Washington, Wisconsin, Wyoming.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1041-2020 (October 7, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1041-2020 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.